2015 Q4 Form 10-Q Financial Statement

#000089817315000189 Filed on November 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $1.949B $2.080B $1.877B
YoY Change 10.48% 10.83% 8.61%
Cost Of Revenue $921.4M $990.9M $908.7M
YoY Change 8.13% 9.05% 7.05%
Gross Profit $1.028B $1.089B $968.2M
YoY Change 12.67% 12.5% 10.13%
Gross Profit Margin 52.73% 52.36% 51.59%
Selling, General & Admin $665.0M $674.0M $624.4M
YoY Change 9.18% 7.94% 7.89%
% of Gross Profit 64.71% 61.88% 64.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $52.20M $52.10M $48.50M
YoY Change 2.96% 7.42% 4.53%
% of Gross Profit 5.08% 4.78% 5.01%
Operating Expenses $665.0M $674.0M $624.4M
YoY Change 9.18% 7.94% 7.89%
Operating Profit $362.6M $415.3M $343.8M
YoY Change 19.67% 20.8% 14.44%
Interest Expense -$13.50M -$13.70M -$12.40M
YoY Change 0.0% 10.48% -3.13%
% of Operating Profit -3.72% -3.3% -3.61%
Other Income/Expense, Net $500.0K -$14.39M -$11.45M
YoY Change -16.67% 25.69% -5.3%
Pretax Income $349.6M $400.9M $332.3M
YoY Change 20.51% 20.63% 15.27%
Income Tax $131.1M $134.6M $115.3M
% Of Pretax Income 37.5% 33.58% 34.7%
Net Earnings $218.6M $266.3M $217.0M
YoY Change 20.31% 22.71% 16.36%
Net Earnings / Revenue 11.21% 12.8% 11.56%
Basic Earnings Per Share $2.22 $2.68 $2.10
Diluted Earnings Per Share $2.19 $2.64 $2.06
COMMON SHARES
Basic Shares Outstanding 98.64M shares 99.27M shares 103.5M shares
Diluted Shares Outstanding 100.8M shares 105.2M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $116.0M $277.0M $298.0M
YoY Change -53.78% -7.05% -17.91%
Cash & Equivalents $116.3M $276.9M $298.3M
Short-Term Investments
Other Short-Term Assets $29.02M $33.09M $34.69M
YoY Change -38.01% -4.62% 2.03%
Inventory $2.631B $2.607B $2.518B
Prepaid Expenses
Receivables $161.1M $163.9M $152.8M
Other Receivables $73.00M $77.00M $67.00M
Total Short-Term Assets $3.010B $3.158B $3.071B
YoY Change -1.81% 2.83% 3.18%
LONG-TERM ASSETS
Property, Plant & Equipment $2.862B $2.805B $2.601B
YoY Change 7.64% 7.84% 9.38%
Goodwill $757.1M $757.1M $756.3M
YoY Change 0.1% 0.1%
Intangibles $12.40M
YoY Change -16.81%
Long-Term Investments
YoY Change
Other Assets $34.74M $41.19M $32.70M
YoY Change -9.55% 25.99% 63.48%
Total Long-Term Assets $3.667B $3.618B $3.404B
YoY Change 5.77% 6.26% 6.69%
TOTAL ASSETS
Total Short-Term Assets $3.010B $3.158B $3.071B
Total Long-Term Assets $3.667B $3.618B $3.404B
Total Assets $6.677B $6.775B $6.475B
YoY Change 2.21% 4.63% 5.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.608B $2.626B $2.409B
YoY Change 7.9% 9.01% 16.04%
Accrued Expenses $131.0M $149.0M $130.0M
YoY Change -7.09% 14.62% 23.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $3.046B $3.104B $2.846B
YoY Change 8.29% 9.06% 16.68%
LONG-TERM LIABILITIES
Long-Term Debt $1.390B $1.397B $1.396B
YoY Change 0.15% 0.07% 0.0%
Other Long-Term Liabilities $199.2M $200.1M $194.6M
YoY Change -4.95% 2.84% -2.72%
Total Long-Term Liabilities $1.589B $200.1M $194.6M
YoY Change 658.39% 2.84% -87.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.046B $3.104B $2.846B
Total Long-Term Liabilities $1.589B $200.1M $194.6M
Total Liabilities $4.636B $3.304B $3.040B
YoY Change 53.35% 8.67% -26.4%
SHAREHOLDERS EQUITY
Retained Earnings $678.8M $732.7M $806.6M
YoY Change -17.46% -9.16%
Common Stock $1.282B $1.269B $1.170B
YoY Change 7.24% 8.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.961B $2.002B $1.976B
YoY Change
Total Liabilities & Shareholders Equity $6.677B $6.775B $6.475B
YoY Change 2.21% 4.63% 5.0%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $218.6M $266.3M $217.0M
YoY Change 20.31% 22.71% 16.36%
Depreciation, Depletion And Amortization $52.20M $52.10M $48.50M
YoY Change 2.96% 7.42% 4.53%
Cash From Operating Activities $282.8M $364.2M $327.5M
YoY Change 36.35% 11.21% 16.8%
INVESTING ACTIVITIES
Capital Expenditures -$117.5M -$110.0M -$122.3M
YoY Change 4.17% -10.06% -0.49%
Acquisitions
YoY Change
Other Investing Activities $1.600M $1.600M $2.500M
YoY Change 6.67% -36.0% 13.64%
Cash From Investing Activities -$116.0M -$108.3M -$119.8M
YoY Change 4.22% -9.6% -0.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -327.5M -239.1M -362.8M
YoY Change 127.59% -34.1% 123.12%
NET CHANGE
Cash From Operating Activities 282.8M 364.2M 327.5M
Cash From Investing Activities -116.0M -108.3M -119.8M
Cash From Financing Activities -327.5M -239.1M -362.8M
Net Change In Cash -160.7M 16.80M -155.1M
YoY Change 236.19% -110.83% 5070.0%
FREE CASH FLOW
Cash From Operating Activities $282.8M $364.2M $327.5M
Capital Expenditures -$117.5M -$110.0M -$122.3M
Free Cash Flow $400.3M $474.2M $449.8M
YoY Change 25.02% 5.42% 11.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000898173
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
98639942 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
O REILLY AUTOMOTIVE INC
CY2014Q4 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
62946000 USD
CY2015Q3 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
65010000 USD
CY2014Q4 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0 USD
CY2015Q3 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0 USD
orly Number Of Days Per Year In Interest Calculation
NumberOfDaysPerYearInInterestCalculation
360 D
CY2014Q3 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
141.77
orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
139.13
CY2015Q3 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
218.21
orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
210.49
CY2015Q1 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
500000000 USD
CY2015Q2 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
500000000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2417167000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2626126000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143900000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
163889000 USD
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2015Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
17574000 USD
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
78442000 USD
CY2015Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
84295000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1334949000 USD
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1470199000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1194929000 USD
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1268357000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1563000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1578000 USD
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
257000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.58
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
2018418000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
2002086000 USD
CY2015Q3 us-gaap Assets
Assets
6775266000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
3066978000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
328000 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
176000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
256000 shares
CY2014Q4 us-gaap Assets
Assets
6540301000 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
3157564000 USD
CY2014Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
25000 USD
CY2015Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0 USD
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
25000 USD
CY2015Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
0 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
231318000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
298283000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
250560000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
276916000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
66965000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26356000 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101602935 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
98714308 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101602935 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
98714308 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1016000 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
987000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
908671000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2655109000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
990947000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2882618000 USD
CY2014Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1396640000 USD
CY2015Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1396995000 USD
us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
Each of the senior notes is subject to certain customary covenants, with which the Company complied as of September 30, 2015.
us-gaap Debt Instrument Description
DebtInstrumentDescription
The Company has issued $1.4 billion aggregate principal amount of unsecured senior notes due between January of 2021 and June of 2023 with United Missouri Bank, N.A. as trustee. Interest on the senior notes, ranging from 3.800% to 4.875%, is payable biannually and is computed on the basis of a 360-day year.
us-gaap Debt Instrument Interest Rate Stated Percentage Rate Range Maximum
DebtInstrumentInterestRateStatedPercentageRateRangeMaximum
0.04875 Rate
us-gaap Debt Instrument Interest Rate Stated Percentage Rate Range Minimum
DebtInstrumentInterestRateStatedPercentageRateRangeMinimum
0.038 Rate
us-gaap Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
2023-06-20
us-gaap Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
2021-01-14
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-18108000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-22780000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
17258000 USD
CY2015Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
7445000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
85164000 USD
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
72197000 USD
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.06
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
143515000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
158065000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.67
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.68
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.98
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
32296000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
50759000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
32296000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
50759000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
756384000 USD
CY2015Q3 us-gaap Goodwill
Goodwill
757093000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
968201000 USD
us-gaap Gross Profit
GrossProfit
2796794000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
1089254000 USD
us-gaap Gross Profit
GrossProfit
3135004000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
332318000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
932076000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
400868000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1110740000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
115321000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
335572000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
134600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
398100000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
308029000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
342920000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
352533000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
208959000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26167000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24511000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
51043000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
85428000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
142880000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
52024000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-36022000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-25276000 USD
CY2015Q3 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
1100000 USD
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
700000 USD
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1724000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1799000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1500000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1573000 shares
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1708000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
39211000 USD
CY2015Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
14296000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
43017000 USD
us-gaap Interest Paid Net
InterestPaidNet
47173000 USD
us-gaap Interest Paid Net
InterestPaidNet
51003000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
2554789000 USD
CY2015Q3 us-gaap Inventory Net
InventoryNet
2606813000 USD
CY2014Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
15378000 USD
CY2015Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
16112000 USD
CY2014Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
12983000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6540301000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6775266000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2830556000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3103912000 USD
CY2015Q3 us-gaap Long Term Debt
LongTermDebt
1400000000 USD
CY2014Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1396615000 USD
CY2015Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1396995000 USD
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
18800000 USD
us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
12500000 USD
us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
Meridian Creative Alliance
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-603906000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-745117000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-312083000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-291249000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
982954000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1062722000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
216997000 USD
us-gaap Net Income Loss
NetIncomeLoss
596504000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
266268000 USD
us-gaap Net Income Loss
NetIncomeLoss
712640000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11450000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-35286000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14392000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-40661000 USD
CY2014Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
69311000 USD
CY2015Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
76861000 USD
CY2014Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
13349000 USD
CY2015Q3 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
14265000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
343768000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
967362000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
415260000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1151401000 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
48418000 USD
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
33085000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1688000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45030000 USD
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41194000 USD
CY2014Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
551000 USD
CY2015Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
551000 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
189836000 USD
CY2015Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
234211000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
209548000 USD
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
200076000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3801000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4194000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
982000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2237000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-647000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
648000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
687154000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
849202000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
317157000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
296474000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
2770000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
3028000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2304000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2197000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
51006000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
53351000 USD
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
34226000 USD
CY2015Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
33889000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
45712000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
45375000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3993509000 USD
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4275349000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2658560000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2805150000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
54000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
25000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
822473000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
732742000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1876872000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
5451903000 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
2080201000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
6017622000 USD
CY2014Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
64882000 USD
CY2015Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
69251000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
624433000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1829432000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
673994000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1983603000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
17424000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
16656000 USD
CY2015Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5500000000 USD
CY2015Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2015Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2015Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
430200000 USD
CY2014Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2542000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
4564000 shares
CY2015Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1147000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3784000 shares
CY2014Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
152.42
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
150.55
CY2015Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
238.97
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
224.39
CY2014Q3 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
387461000 USD
us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
687086000 USD
CY2015Q3 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
274213000 USD
us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
849145000 USD
CY2014Q4 us-gaap Unsecured Debt
UnsecuredDebt
0 USD
CY2015Q3 us-gaap Unsecured Debt
UnsecuredDebt
0 USD
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105222000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106945000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100770000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102041000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103498000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105146000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99270000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100468000 shares
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 1 - BASIS OF PRESENTATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements of O'Reilly Automotive, Inc. and its subsidiaries (the "Company" or "O'Reilly") have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, are not necessarily indicative of the results that may be expected for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 9 - RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May of 2014, the Financial Accounting Standards Board (the "FASB") issued Accounting Standard Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers (Topic 606)" ("ASU 2014-09"). Under ASU 2014-09, an entity is required to follow a five-step process to determine the amount of revenue to recognize when promised goods or services are transferred to customers. ASU 2014-09 offers specific accounting guidance for costs to obtain or fulfill a contract with a customer. In addition, an entity is required to disclose sufficient information to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. In August of 2015, the FASB issued ASU No. 2015-14, "Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date" ("ASU 2015-14"), to defer the effective date of ASU 2014-09 by one year. Originally, for public companies, ASU 2014-09 was effective for annual reporting periods beginning after December 15, 2016, including periods within that reporting period, and could be adopted either retrospectively or as a cumulative effect adjustment at the date of adoption, with early adoption not permitted. For public companies, ASU 2015-14 changes ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017, including periods within that reporting period, and can be adopted retrospectively or as a cumulative effective adjustment at the date of adoption, with early adoption allowed, but not before ASU 2014-09's original effective date of December 15, 2016. The Company will adopt this guidance beginning with its first quarter ending March 31, 2018. The Company is in the process of evaluating the potential future impact, if any, of ASU 2014-09 on its consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">In January of 2015, the FASB issued ASU No. 2015-01, "Extraordinary and Unusual Items (Subtopic 225-20)" ("ASU 2015-01"). ASU 2015-01 eliminates from U.S. GAAP the concept of extraordinary items; such that, an entity will no longer need to assess whether a particular event or transaction event is extraordinary. ASU 2015-01 is effective for annual reporting periods beginning after December 15, 2015, including periods within that reporting period, and early adoption is permitted. The Company will adopt this guidance beginning with its first quarter ending March 31, 2016. The application of this guidance is not expected to have a material impact on the Company's consolidated financial condition, results of operations or cash flows. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">In April of 2015, the FASB issued ASU No. 2015-03, "Interest - Imputation of Interest (Subtopic 835-30)" ("ASU 2015-03"). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. In August of 2015, the FASB issued ASU 2015-15, "Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements - Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015, EITF Meeting" ("ASU 2015-15"), to update ASU 2015-03 to reflect a Securities and Exchange Commission change. ASU 2015-15 allows an entity, in the case of a line-of-credit arrangement, to either follow ASU 2015-03 or defer and present debt issuance costs as an asset and subsequently amortize the deferred debt issuance costs ratable over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. ASU 2015-03 is effective for annual reporting periods beginning after December 15, 2015, including periods within that reporting period, requires retrospective application, and early adoption is permitted. The Company will adopt this guidance with its first quarter ending March 31, 2016. The application of this guidance affects classification only, and therefore, it is not expected to have a material impact on the Company's consolidated financial condition, results of operations or cash</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">flows.</font></div></div>

Files In Submission

Name View Source Status
0000898173-15-000189-index-headers.html Edgar Link pending
0000898173-15-000189-index.html Edgar Link pending
0000898173-15-000189.txt Edgar Link pending
0000898173-15-000189-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
orly-20150930.xml Edgar Link completed
orly-20150930.xsd Edgar Link pending
orly-20150930x10q.htm Edgar Link pending
orly-20150930x10qexhibit311.htm Edgar Link pending
orly-20150930x10qexhibit312.htm Edgar Link pending
orly-20150930x10qexhibit321.htm Edgar Link pending
orly-20150930x10qexhibit322.htm Edgar Link pending
orly-20150930_cal.xml Edgar Link unprocessable
orly-20150930_def.xml Edgar Link unprocessable
orly-20150930_lab.xml Edgar Link unprocessable
orly-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending